Atherosclerotic cardiovascular disease thresholds for statin initiation among people living with HIV in Thailand: A cost-effectiveness analysis.
<h4>Background</h4>People living with HIV (PLHIV) have an elevated risk of atherosclerotic cardiovascular disease (ASCVD) compared to their uninfected peers. Expanding statin use may help alleviate this burden. We evaluated the cost-effectiveness of reducing the recommend statin initiati...
Guardado en:
Autores principales: | David C Boettiger, Pairoj Chattranukulchai, Anchalee Avihingsanon, Romanee Chaiwarith, Suwimon Khusuwan, Matthew G Law, Jeremy Ross, Sasisopin Kiertiburanakul |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/ca934aaea5ca4a18bd5c1789b32e3f7e |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
The association of atherosclerotic cardiovascular disease and statin use with inflammation and treatment outcomes in tuberculosis
por: Vignesh Chidambaram, et al.
Publicado: (2021) -
Similar major cardiovascular outcomes between pure statin and ezetimibe-statin in comparable intensity for type 2 diabetes with extremely atherosclerotic risks
por: Yu-Cheng Kao, et al.
Publicado: (2021) -
Prognostic effect of high-density lipoprotein cholesterol level in patients with atherosclerotic cardiovascular disease under statin treatment
por: Yi-Heng Li, et al.
Publicado: (2020) -
The gut microbiome in atherosclerotic cardiovascular disease
por: Zhuye Jie, et al.
Publicado: (2017) -
The Initial Human Atherosclerotic Lesion and Lipoprotein Modification—A Deep Connection
por: Michael Torzewski
Publicado: (2021)